Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk

Posted October 25, 2024

A new study finds type 2 diabetes patients taking semaglutide have much lower odds of developing Alzheimer’s disease, regardless of weight, gender or age.

Health News is provided as a service to J Drugs II site users by HealthDay. J Drugs II nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Get Healthy!

Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk

Health News is provided as a service to J Drugs II site users by HealthDay. J Drugs II nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2024 HealthDay All Rights Reserved.

Tags

Site Navigation

Contact Us

Patient Resources

Get Healthy!

Popular Diabetes and Weight-loss Drug May Lower Alzheimer’s Risk

Health News is provided as a service to J Drugs II site users by HealthDay. J Drugs II nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags

Site Navigation

Contact Us